{"id":5400,"date":"2025-02-05T14:48:53","date_gmt":"2025-02-05T14:48:53","guid":{"rendered":"https:\/\/itbusinesstoday.com\/?p=5400"},"modified":"2025-04-16T16:04:03","modified_gmt":"2025-04-16T16:04:03","slug":"enyu-pharma-raises-400m-yen-in-seed-funding-for-glycopeptide-antibody-drugs","status":"publish","type":"post","link":"https:\/\/itbusinesstoday.com\/ja\/health-tech\/pharma\/enyu-pharma-raises-400m-yen-in-seed-funding-for-glycopeptide-antibody-drugs\/","title":{"rendered":"\u30a8\u30f3\u30e6\u30d5\u30a1\u30fc\u30de\u3001\u7cd6\u30da\u30d7\u30c1\u30c9\u6297\u4f53\u533b\u85ac\u54c1\u30674\u5104\u5186\u306e\u30b7\u30fc\u30c9\u8cc7\u91d1\u3092\u8abf\u9054"},"content":{"rendered":"

\u7cd6\u30da\u30d7\u30c1\u30c9\u3092\u65b0\u305f\u306a\u5275\u85ac\u30bf\u30fc\u30b2\u30c3\u30c8\u3068\u3057\u3066\u3001\u672a\u3060\u6cbb\u7642\u6cd5\u306e\u78ba\u7acb\u3055\u308c\u3066\u3044\u306a\u3044\u75be\u60a3\u306b\u5bfe\u3059\u308b\u533b\u85ac\u54c1\u958b\u767a\u3092\u76ee\u6307\u3059\u30a8\u30f3\u30e6\u30d5\u30a1\u30fc\u30de\u682a\u5f0f\u4f1a\u793e\u306f\u30012024\u5e7412\u6708\u306b\u4eac\u90fd\u5927\u5b66\u30a4\u30ce\u30d9\u30fc\u30b7\u30e7\u30f3\u30ad\u30e3\u30d4\u30bf\u30eb\u682a\u5f0f\u4f1a\u793e\u3001\u5927\u9d6c\u30a4\u30ce\u30d9\u30fc\u30b7\u30e7\u30f3\u30ba\u5408\u540c\u4f1a\u793e\u3001\u682a\u5f0f\u4f1a\u793eDG\u30a4\u30f3\u30ad\u30e5\u30d9\u30fc\u30b7\u30e7\u30f3\u3001\u682a\u5f0f\u4f1a\u793e\u5317\u6d77\u9053\u5171\u5275\u30d1\u30fc\u30c8\u30ca\u30fc\u30ba\u3092\u5f15\u53d7\u5148\u3068\u3059\u308b\u7b2c\u4e09\u8005\u5272\u5f53\u5897\u8cc7\u3092\u5b9f\u65bd\u3057\u3001\u7dcf\u984d4\u5104\u5186\u306e\u30b7\u30fc\u30c9\u30e9\u30a6\u30f3\u30c9\u8cc7\u91d1\u3092\u8abf\u9054\u3057\u307e\u3057\u305f\u3002\u307e\u305f\u3001\u4eac\u90fd\u5927\u5b66\u30a4\u30ce\u30d9\u30fc\u30b7\u30e7\u30f3\u30fb\u30ad\u30e3\u30d4\u30bf\u30eb\u682a\u5f0f\u4f1a\u793e\u306e\u8fbb\u6751\u525b\u6c0f\u3001\u5927\u9d6c\u30a4\u30ce\u30d9\u30fc\u30b7\u30e7\u30f3\u30ba\u5408\u540c\u4f1a\u793e\u306e\u68ee\u6587\u9686\u6c0f\u304c\u65b0\u305f\u306b\u793e\u5916\u53d6\u7de0\u5f79\u306b\u5c31\u4efb\u3044\u305f\u3057\u307e\u3057\u305f\u3002<\/p>\n

\u672c\u8cc7\u91d1\u8abf\u9054\u306e\u76ee\u7684<\/strong><\/p>\n

\u4eca\u56de\u306e\u8abf\u9054\u8cc7\u91d1\u306f\u3001\u5317\u6d77\u9053\u5927\u5b66\u5927\u5b66\u9662\u306e\u897f\u6751\u771f\u4e00\u90ce\u6559\u6388\u304c\u767a\u898b\u3057\u305f\u7cd6\u30da\u30d7\u30c1\u30c9\u3092\u6a19\u7684\u3068\u3057\u305f\u753b\u671f\u7684\u306a\u6297\u539f\u63d0\u793a\u6cd5\u306b\u57fa\u3065\u304f\u3001\u9078\u629e\u6027\u306e\u9ad8\u3044\u6297\u4f53\u533b\u85ac\u3092\u5275\u88fd\u3059\u308b\u6280\u8853\u306e\u5b9f\u7528\u5316\u306b\u5411\u3051\u305f\u30ad\u30c3\u30af\u30aa\u30d5\u8cc7\u91d1\u3068\u3057\u3066\u6d3b\u7528\u3055\u308c\u307e\u3059\u3002\u5177\u4f53\u7684\u306b\u306f\u3001\u304c\u3093\u3060\u3051\u3067\u306a\u304f\u3001\u81ea\u5df1\u514d\u75ab\u75be\u60a3\u3084\u8a8d\u77e5\u75c7\u306a\u3069\u5e45\u5e83\u3044\u75be\u60a3\u306b\u5bfe\u3057\u3066\u3001\u5fc5\u8981\u306a\u4eba\u306b\u5fc5\u8981\u306a\u85ac\u3092\u8fc5\u901f\u306b\u5c4a\u3051\u308b\u3053\u3068\u3092\u4fc3\u9032\u3059\u308b\u305f\u3081\u306e\u8cc7\u6e90\u3068\u3057\u3066\u6d3b\u7528\u3055\u308c\u307e\u3059\u3002<\/p>\n

\u3053\u3061\u3089\u3082\u304a\u8aad\u307f\u304f\u3060\u3055\u3044\uff1a NEC\u3068\u30d0\u30a4\u30aa\u30df\u30fc\u3001\u30c7\u30b8\u30bf\u30eb\u75c5\u7406\u5206\u91ce\u306b\u304a\u3051\u308b\u89e3\u6790\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u306e\u958b\u767a\u30fb\u62e1\u5927\u3067\u63d0\u643a<\/a><\/strong><\/h3>\n

\u95a2\u4fc2\u8005\u304b\u3089\u306e\u30b3\u30e1\u30f3\u30c8<\/strong><\/p>\n

\u4ee3\u8868\u53d6\u7de0\u5f79\u793e\u9577 \u5b89\u4e95\u5fe0\u826f<\/strong><\/p>\n

\u4eca\u56de\u306e\u8cc7\u91d1\u8abf\u9054\u3092\u5b8c\u4e86\u3067\u304d\u305f\u3053\u3068\u3092\u975e\u5e38\u306b\u559c\u3070\u3057\u304f\u601d\u3063\u3066\u304a\u308a\u3001\u6295\u8cc7\u3057\u3066\u304f\u3060\u3055\u3063\u305f\u3059\u3079\u3066\u306e\u4f01\u696d\u306b\u5fc3\u304b\u3089\u611f\u8b1d\u7533\u3057\u4e0a\u3052\u307e\u3059\u3002<\/p>\n

\u5f53\u793e\u306f2019\u5e74\u306e\u5275\u696d\u4ee5\u6765\u3001\u9577\u5e74\u7814\u7a76\u3057\u3066\u304d\u305f\u7cd6\u9396\u89e3\u6790\u6280\u8853\u3084\u6297\u539f\u63d0\u793a\u6cd5\u3092\u533b\u85ac\u54c1\u7814\u7a76\u958b\u767a\u306b\u5fdc\u7528\u3067\u304d\u308b\u3088\u3046\u3001\u7cbe\u5ea6\u30fb\u6a5f\u80fd\u30fb\u6280\u8853\u306e\u5411\u4e0a\u306b\u52aa\u3081\u3066\u307e\u3044\u308a\u307e\u3057\u305f\u3002\u75be\u60a3\u7279\u7570\u7684\u306a\u7cd6\u9396\u69cb\u9020\u306e\u5f79\u5272\u306e\u89e3\u6790\u306f\u3001\u4ed6\u793e\u3092\u51cc\u99d5\u3059\u308b\u30ec\u30d9\u30eb\u306b\u9054\u3057\u3066\u3044\u308b\u3068\u8003\u3048\u3066\u304a\u308a\u307e\u3059\u3002<\/p>\n

\u6b21\u306e\u30b9\u30c6\u30fc\u30b8\u306f\u3001\u79c1\u305f\u3061\u306e\u6280\u8853\u3092\u533b\u85ac\u54c1\u958b\u767a\u306b\u5fdc\u7528\u3059\u308b\u3053\u3068\u3067\u3042\u308a\u3001\u305d\u306e\u305f\u3081\u306b\u3082\u4eca\u56de\u306e\u8cc7\u91d1\u8abf\u9054\u306f\u4e0d\u53ef\u6b20\u3067\u3057\u305f\u3002\u3053\u306e\u8cc7\u91d1\u3068\u30b9\u30c6\u30fc\u30af\u30db\u30eb\u30c0\u30fc\u306e\u7686\u69d8\u306e\u3054\u6307\u5c0e\u306e\u3082\u3068\u3001\u3088\u308a\u6709\u52b9\u306a\u6297\u4f53\u533b\u85ac\u54c1\u3092\u4e00\u65e5\u3082\u65e9\u304f\u60a3\u8005\u3055\u3093\u306b\u304a\u5c4a\u3051\u3067\u304d\u308b\u3088\u3046\u3001\u5168\u529b\u3092\u5c3d\u304f\u3057\u3066\u307e\u3044\u308a\u307e\u3059\u3002<\/p>\n

\u4eac\u90fd\u5927\u5b66\u30a4\u30ce\u30d9\u30fc\u30b7\u30e7\u30f3\u30fb\u30ad\u30e3\u30d4\u30bf\u30eb\u682a\u5f0f\u4f1a\u793e \u6295\u8cc7\u90e8 \u90e8\u9577 \u8fbb\u6751\u525b\u6c0f<\/strong><\/p>\n

\u30a8\u30f3\u30e6\u30d5\u30a1\u30fc\u30de\u682a\u5f0f\u4f1a\u793e\u306f\u3001\u72ec\u81ea\u306e\u7cd6\u9396\u89e3\u6790\u6280\u8853\u3092\u99c6\u4f7f\u3057\u3001\u65b0\u305f\u306a\u5275\u85ac\u30bf\u30fc\u30b2\u30c3\u30c8\u3092\u767a\u898b\u3059\u308b\u80fd\u529b\u3092\u6709\u3057\u3066\u3044\u307e\u3059\u3002\u3053\u306e\u6280\u8853\u306f\u3001\u75be\u60a3\u306b\u304a\u3051\u308b\u7cd6\u9396\u306e\u69cb\u9020\u7684\u5f79\u5272\u3092\u6df1\u304f\u7406\u89e3\u3059\u308b\u3053\u3068\u3067\u3001\u3053\u308c\u307e\u3067\u6cbb\u7642\u304c\u56f0\u96e3\u3067\u3042\u3063\u305f\u9818\u57df\u306b\u304a\u3044\u3066\u3082\u753b\u671f\u7684\u306a\u6297\u4f53\u533b\u85ac\u306e\u958b\u767a\u3092\u53ef\u80fd\u306b\u3057\u307e\u3059\u3002\u307e\u305f\u3001\u5f53\u793e\u306e\u6297\u4f53\u4f5c\u88fd\u6280\u8853\u306f\u3001\u3053\u308c\u307e\u3067\u5165\u624b\u304c\u56f0\u96e3\u3067\u3042\u3063\u305f\u9ad8\u7cbe\u5ea6\u306a\u7cd6\u9396\u7279\u7570\u7684\u6297\u4f53\u3092\u53d6\u5f97\u3059\u308b\u3053\u3068\u3067\u3001\u75be\u60a3\u7279\u7570\u6027\u30fb\u7d44\u7e54\u7279\u7570\u6027\u3092\u9ad8\u3081\u305f\u533b\u85ac\u54c1\u6297\u4f53\u3092\u8fc5\u901f\u304b\u3064\u52b9\u7387\u7684\u306b\u4f5c\u88fd\u3057\u3001\u6297\u4f53\u533b\u85ac\u306e\u6982\u5ff5\u3092\u5927\u304d\u304f\u5909\u3048\u308b\u53ef\u80fd\u6027\u3092\u79d8\u3081\u3066\u3044\u307e\u3059\u3002<\/p>\n

\u4eac\u90fd\u5927\u5b66\u30a4\u30ce\u30d9\u30fc\u30b7\u30e7\u30f3\u30ad\u30e3\u30d4\u30bf\u30eb\u682a\u5f0f\u4f1a\u793e\u306f\u3001\u672c\u51fa\u8cc7\u3092\u901a\u3058\u3066\u3001\u304c\u3093\u3092\u306f\u3058\u3081\u3068\u3059\u308b\u30a2\u30f3\u30e1\u30c3\u30c8\u30e1\u30c7\u30a3\u30ab\u30eb\u30cb\u30fc\u30ba\u306e\u9ad8\u3044\u96e3\u6cbb\u6027\u75be\u60a3\u306b\u5bfe\u3059\u308b\u65b0\u305f\u306a\u6cbb\u7642\u6cd5\u306e\u5b9f\u73fe\u306b\u8ca2\u732e\u3059\u308b\u3053\u3068\u3092\u76ee\u6307\u3057\u307e\u3059\u3002\u7279\u306b\u3001\u7cd6\u9396\u89e3\u6790\u6280\u8853\u3092\u7528\u3044\u305f\u65b0\u305f\u306a\u5275\u85ac\u30bf\u30fc\u30b2\u30c3\u30c8\u306e\u767a\u898b\u3068\u3001\u305d\u308c\u306b\u57fa\u3065\u304f\u75be\u60a3\u7279\u7570\u7684\u306a\u6297\u4f53\u533b\u85ac\u306e\u958b\u767a\u306f\u3001\u3053\u308c\u307e\u3067\u6cbb\u7642\u306e\u9078\u629e\u80a2\u304c\u9650\u3089\u308c\u3066\u3044\u305f\u60a3\u8005\u3055\u3093\u306b\u5e0c\u671b\u3092\u3082\u305f\u3089\u3059\u3082\u306e\u3068\u78ba\u4fe1\u3057\u3066\u304a\u308a\u307e\u3059\u3002<\/p>\n

\u68ee \u6587\u9686 \u30d1\u30fc\u30c8\u30ca\u30fc\u3001Taiho Innovations LLC<\/strong><\/p>\n

2\u5e74\u524d\u306b\u30a8\u30f3\u30e6\u30d5\u30a1\u30fc\u30de\u306e\u3053\u3068\u3092\u521d\u3081\u3066\u77e5\u3063\u305f\u6642\u3001\u75be\u60a3\u7279\u7570\u7684\u306a\u52d5\u7684\u30a8\u30d4\u30c8\u30fc\u30d7\uff08\u7cd6\u30da\u30d7\u30c1\u30c9\uff09\u3092\u6349\u3048\u308b\u3053\u3068\u3067\u3001\u5f93\u6765\u56f0\u96e3\u3067\u3042\u3063\u305f\u5275\u85ac\u3092\u53ef\u80fd\u306b\u3059\u308b\u9769\u65b0\u7684\u306a\u6280\u8853\u306b\u6df1\u3044\u611f\u9298\u3092\u53d7\u3051\u307e\u3057\u305f\u3002\u4ee5\u6765\u3001\u5275\u85ac\u306e\u30a2\u30d7\u30ed\u30fc\u30c1\u3084\u5b9f\u65bd\u4f53\u5236\u306b\u3064\u3044\u3066\u4f55\u5ea6\u3082\u8b70\u8ad6\u3092\u91cd\u306d\u3001\u4eca\u56de\u3001\u6295\u8cc7\u3068\u3044\u3046\u5f62\u3067\u4e00\u7dd2\u306b\u5275\u85ac\u306b\u30c1\u30e3\u30ec\u30f3\u30b8\u3067\u304d\u308b\u3053\u3068\u3092\u5fc3\u304b\u3089\u5b09\u3057\u304f\u601d\u3063\u3066\u3044\u307e\u3059\u3002Enyu Pharma\u306e\u5275\u85ac\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u306f\u3001\u304c\u3093\u306e\u65e9\u671f\u8a3a\u65ad\u3068\u6cbb\u7642\u4ecb\u5165\u3092\u53ef\u80fd\u306b\u3057\u3001\u5b8c\u6cbb\u3068\u3044\u3046\u58ee\u5927\u306a\u5922\u3092\u5b9f\u73fe\u3059\u308b\u53ef\u80fd\u6027\u3092\u79d8\u3081\u3066\u3044\u307e\u3059\u3002\u5927\u9d6c\u85ac\u54c1\u5de5\u696d\u306f\u3001\u4e16\u754c\u4e2d\u306e\u60a3\u8005\u3055\u3093\u306e\u7b11\u9854\u306e\u305f\u3081\u306b\u3001\u305d\u306e\u5922\u306e\u5b9f\u73fe\u306b\u5411\u3051\u3066\u5168\u529b\u3067\u30b5\u30dd\u30fc\u30c8\u3057\u3066\u307e\u3044\u308a\u307e\u3059\u3002<\/p>\n

\u30bd\u30fc\u30b9 PR TIMES<\/a><\/strong><\/p>","protected":false},"excerpt":{"rendered":"

Enyu Pharma Co., Ltd., which aims to develop medicines for diseases for which there are no outstanding treatments using glycopeptides as a new drug discovery target, raised a total of 400 million yen in a seed round in December 2024 through a third-party allotment of new shares to Kyoto University Innovation Capital Co., Ltd., Taiho Innovations LLC, DG Incubation Inc., and Hokkaido Co-Creation Partners Inc. In addition, Tsuyoshi Tsujimura of Kyoto University Innovation Capital Co., Ltd. and Fumitaka Mori of Taiho Innovations LLC have been appointed as new outside directors. Purpose of this fundraising The funds raised will be used to kick off the practical application of a technology to […]<\/p>\n","protected":false},"author":4,"featured_media":5422,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_bbp_topic_count":0,"_bbp_reply_count":0,"_bbp_total_topic_count":0,"_bbp_total_reply_count":0,"_bbp_voice_count":0,"_bbp_anonymous_reply_count":0,"_bbp_topic_count_hidden":0,"_bbp_reply_count_hidden":0,"_bbp_forum_subforum_count":0,"wprm-recipe-roundup-name":"","wprm-recipe-roundup-description":"","postBodyCss":"","postBodyMargin":[],"postBodyPadding":[],"postBodyBackground":{"backgroundType":"classic","gradient":""},"footnotes":""},"categories":[208,1,89,198,211,237,182,206],"tags":[805,803,804,497,493,105,106,424],"ppma_author":[205],"class_list":{"0":"post-5400","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-apac","8":"category-fintech","9":"category-health-tech","10":"category-investments","11":"category-japan","12":"category-news","13":"category-pharma","14":"category-regional","15":"tag-antibody-drugs","16":"tag-enyu-pharma","17":"tag-glycopeptides","18":"tag-healthtech","19":"tag-investments","20":"tag-itbusinesstoday","21":"tag-news","22":"tag-pharma"},"yoast_head":"\nEnyu Pharma Raises 400M Yen in Seed Funding<\/title>\n<meta name=\"description\" content=\"Enyu Pharma raises 400 million yen in seed funding for glycopeptide-based drug discovery and appoints new outside directors.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/itbusinesstoday.com\/ja\/fintech\/enyu-pharma-raises-400m-yen-in-seed-funding-for-glycopeptide-antibody-drugs\/\" \/>\n<meta property=\"og:locale\" content=\"ja_JP\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Enyu Pharma Raises 400M Yen in Seed Funding\" \/>\n<meta property=\"og:description\" content=\"Enyu Pharma raises 400 million yen in seed funding for glycopeptide-based drug discovery and appoints new outside directors.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/itbusinesstoday.com\/ja\/fintech\/enyu-pharma-raises-400m-yen-in-seed-funding-for-glycopeptide-antibody-drugs\/\" \/>\n<meta property=\"og:site_name\" content=\"itbusinesstoday\" \/>\n<meta property=\"article:published_time\" content=\"2025-02-05T14:48:53+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-04-16T16:04:03+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/02\/Enyu-Pharma_-a-company-developing-antibody-drugs-using-glycopeptides-as-a-new-drug-discovery-target_-raises-a-total-of-400-million-yen-in-seed-funding.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"800\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"NewsDesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u57f7\u7b46\u8005\" \/>\n\t<meta name=\"twitter:data1\" content=\"NewsDesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593\" \/>\n\t<meta name=\"twitter:data2\" content=\"4\u5206\" \/>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"\u30a8\u30f3\u30e6\u30d5\u30a1\u30fc\u30de\u3001\u30b7\u30fc\u30c9\u8cc7\u91d1\u3068\u3057\u30664\u5104\u5186\u3092\u8abf\u9054","description":"\u30a8\u30f3\u30e6\u30d5\u30a1\u30fc\u30de\u3001\u7cd6\u30da\u30d7\u30c1\u30c9\u5275\u85ac\u3067\u30b7\u30fc\u30c9\u8cc7\u91d14\u5104\u5186\u3092\u8abf\u9054\u3001\u65b0\u793e\u5916\u53d6\u7de0\u5f79\u3092\u9078\u4efb.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/itbusinesstoday.com\/ja\/fintech\/enyu-pharma-raises-400m-yen-in-seed-funding-for-glycopeptide-antibody-drugs\/","og_locale":"ja_JP","og_type":"article","og_title":"Enyu Pharma Raises 400M Yen in Seed Funding","og_description":"Enyu Pharma raises 400 million yen in seed funding for glycopeptide-based drug discovery and appoints new outside directors.","og_url":"https:\/\/itbusinesstoday.com\/ja\/fintech\/enyu-pharma-raises-400m-yen-in-seed-funding-for-glycopeptide-antibody-drugs\/","og_site_name":"itbusinesstoday","article_published_time":"2025-02-05T14:48:53+00:00","article_modified_time":"2025-04-16T16:04:03+00:00","og_image":[{"width":1200,"height":800,"url":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/02\/Enyu-Pharma_-a-company-developing-antibody-drugs-using-glycopeptides-as-a-new-drug-discovery-target_-raises-a-total-of-400-million-yen-in-seed-funding.webp","type":"image\/webp"}],"author":"NewsDesk","twitter_card":"summary_large_image","twitter_misc":{"\u57f7\u7b46\u8005":"NewsDesk","\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593":"4\u5206"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/itbusinesstoday.com\/fintech\/enyu-pharma-raises-400m-yen-in-seed-funding-for-glycopeptide-antibody-drugs\/#article","isPartOf":{"@id":"https:\/\/itbusinesstoday.com\/fintech\/enyu-pharma-raises-400m-yen-in-seed-funding-for-glycopeptide-antibody-drugs\/"},"author":{"name":"NewsDesk","@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#\/schema\/person\/d58d81f55e8acd257ab63d49fb4ea812"},"headline":"Enyu Pharma Raises 400M Yen in Seed Funding for Glycopeptide Antibody Drugs","datePublished":"2025-02-05T14:48:53+00:00","dateModified":"2025-04-16T16:04:03+00:00","mainEntityOfPage":{"@id":"https:\/\/itbusinesstoday.com\/fintech\/enyu-pharma-raises-400m-yen-in-seed-funding-for-glycopeptide-antibody-drugs\/"},"wordCount":662,"publisher":{"@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#organization"},"image":{"@id":"https:\/\/itbusinesstoday.com\/fintech\/enyu-pharma-raises-400m-yen-in-seed-funding-for-glycopeptide-antibody-drugs\/#primaryimage"},"thumbnailUrl":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/02\/Enyu-Pharma_-a-company-developing-antibody-drugs-using-glycopeptides-as-a-new-drug-discovery-target_-raises-a-total-of-400-million-yen-in-seed-funding.webp","keywords":["antibody drugs","Enyu Pharma","glycopeptides","Healthtech","Investments","itbusinesstoday","News","Pharma"],"articleSection":["APAC","FinTech","Health Tech","Investments","Japan","News","Pharma","Regional"],"inLanguage":"ja"},{"@type":"WebPage","@id":"https:\/\/itbusinesstoday.com\/fintech\/enyu-pharma-raises-400m-yen-in-seed-funding-for-glycopeptide-antibody-drugs\/","url":"https:\/\/itbusinesstoday.com\/fintech\/enyu-pharma-raises-400m-yen-in-seed-funding-for-glycopeptide-antibody-drugs\/","name":"\u30a8\u30f3\u30e6\u30d5\u30a1\u30fc\u30de\u3001\u30b7\u30fc\u30c9\u8cc7\u91d1\u3068\u3057\u30664\u5104\u5186\u3092\u8abf\u9054","isPartOf":{"@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#website"},"primaryImageOfPage":{"@id":"https:\/\/itbusinesstoday.com\/fintech\/enyu-pharma-raises-400m-yen-in-seed-funding-for-glycopeptide-antibody-drugs\/#primaryimage"},"image":{"@id":"https:\/\/itbusinesstoday.com\/fintech\/enyu-pharma-raises-400m-yen-in-seed-funding-for-glycopeptide-antibody-drugs\/#primaryimage"},"thumbnailUrl":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/02\/Enyu-Pharma_-a-company-developing-antibody-drugs-using-glycopeptides-as-a-new-drug-discovery-target_-raises-a-total-of-400-million-yen-in-seed-funding.webp","datePublished":"2025-02-05T14:48:53+00:00","dateModified":"2025-04-16T16:04:03+00:00","description":"\u30a8\u30f3\u30e6\u30d5\u30a1\u30fc\u30de\u3001\u7cd6\u30da\u30d7\u30c1\u30c9\u5275\u85ac\u3067\u30b7\u30fc\u30c9\u8cc7\u91d14\u5104\u5186\u3092\u8abf\u9054\u3001\u65b0\u793e\u5916\u53d6\u7de0\u5f79\u3092\u9078\u4efb.","breadcrumb":{"@id":"https:\/\/itbusinesstoday.com\/fintech\/enyu-pharma-raises-400m-yen-in-seed-funding-for-glycopeptide-antibody-drugs\/#breadcrumb"},"inLanguage":"ja","potentialAction":[{"@type":"ReadAction","target":["https:\/\/itbusinesstoday.com\/fintech\/enyu-pharma-raises-400m-yen-in-seed-funding-for-glycopeptide-antibody-drugs\/"]}]},{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/itbusinesstoday.com\/fintech\/enyu-pharma-raises-400m-yen-in-seed-funding-for-glycopeptide-antibody-drugs\/#primaryimage","url":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/02\/Enyu-Pharma_-a-company-developing-antibody-drugs-using-glycopeptides-as-a-new-drug-discovery-target_-raises-a-total-of-400-million-yen-in-seed-funding.webp","contentUrl":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/02\/Enyu-Pharma_-a-company-developing-antibody-drugs-using-glycopeptides-as-a-new-drug-discovery-target_-raises-a-total-of-400-million-yen-in-seed-funding.webp","width":1200,"height":800,"caption":"Enyu Pharma"},{"@type":"BreadcrumbList","@id":"https:\/\/itbusinesstoday.com\/fintech\/enyu-pharma-raises-400m-yen-in-seed-funding-for-glycopeptide-antibody-drugs\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/itbusinesstoday.com\/"},{"@type":"ListItem","position":2,"name":"Enyu Pharma Raises 400M Yen in Seed Funding for Glycopeptide Antibody Drugs"}]},{"@type":"WebSite","@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#website","url":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/","name":"\u30a4\u30c3\u30c8\u30d3\u30b8\u30cd\u30b9\u30c8\u30a5\u30c7\u30a4","description":"","publisher":{"@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ja"},{"@type":"Organization","@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#organization","name":"\u30a4\u30c3\u30c8\u30d3\u30b8\u30cd\u30b9\u30c8\u30a5\u30c7\u30a4","url":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/","logo":{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#\/schema\/logo\/image\/","url":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Asset-1.png","contentUrl":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Asset-1.png","width":663,"height":275,"caption":"itbusinesstoday"},"image":{"@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#\/schema\/person\/d58d81f55e8acd257ab63d49fb4ea812","name":"\u30cb\u30e5\u30fc\u30b9\u30c7\u30b9\u30af","image":{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/it.png74f313ad3d6fa27a1eee85c30be63d03","url":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/it.png","contentUrl":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/it.png","caption":"NewsDesk"},"sameAs":["https:\/\/itbusinesstoday.com"],"url":"https:\/\/itbusinesstoday.com\/ja\/author\/newsdesk\/"}]}},"authors":[{"term_id":205,"user_id":4,"is_guest":0,"slug":"newsdesk","display_name":"NewsDesk","avatar_url":{"url":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/it.png","url2x":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/it.png"},"0":null,"1":"","2":"","3":"","4":"","5":"","6":"","7":"","8":""}],"_links":{"self":[{"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/posts\/5400","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/comments?post=5400"}],"version-history":[{"count":1,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/posts\/5400\/revisions"}],"predecessor-version":[{"id":5401,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/posts\/5400\/revisions\/5401"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/media\/5422"}],"wp:attachment":[{"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/media?parent=5400"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/categories?post=5400"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/tags?post=5400"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/ppma_author?post=5400"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}